CryoPort, Inc. (NASDAQ:CYRX) CEO Jerrell Shelton Sells 119,281 Shares

CryoPort, Inc. (NASDAQ:CYRX - Get Free Report) CEO Jerrell Shelton sold 119,281 shares of the business's stock in a transaction that occurred on Wednesday, June 18th. The shares were sold at an average price of $6.81, for a total value of $812,303.61. Following the transaction, the chief executive officer now directly owns 912,419 shares in the company, valued at $6,213,573.39. This trade represents a 11.56% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Jerrell Shelton also recently made the following trade(s):

• On Tuesday, June 17th, Jerrell Shelton sold 151,304 shares of CryoPort stock. The stock was sold at an average price of $6.81, for a total value of $1,030,380.24.
• On Friday, June 20th, Jerrell Shelton sold 69,135 shares of CryoPort stock. The shares were sold at an average price of $6.47, for a total transaction of $447,303.45.
• On Monday, March 24th, Jerrell Shelton sold 2,980 shares of CryoPort stock. The stock was sold at an average price of $6.94, for a total transaction of $20,681.20.

CryoPort Stock Up 3.0%

Shares of CYRX stock traded up $0.19 during trading hours on Monday, hitting $6.56. 572,912 shares of the company's stock traded hands, compared to its average volume of 529,975. The company has a quick ratio of 5.24, a current ratio of 5.56 and a debt-to-equity ratio of 0.51. The stock's fifty day simple moving average is $6.20 and its two-hundred day simple moving average is $6.70. CryoPort, Inc. has a 12-month low of $4.58 and a 12-month high of $9.78. The stock has a market cap of $328.92 million, a price-to-earnings ratio of -2.80 and a beta of 1.85.

CryoPort (NASDAQ:CYRX - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.23) by $0.01. CryoPort had a negative return on equity of 11.03% and a negative net margin of 50.15%. The business had revenue of $41.04 million during the quarter, compared to analysts' expectations of $56.19 million. On average, analysts expect that CryoPort, Inc. will post -0.99 EPS for the current year.

Analyst Ratings Changes

CYRX has been the topic of several research analyst reports. Guggenheim reiterated a "buy" rating and set a $10.00 price target on shares of CryoPort in a research report on Wednesday, April 16th. Needham & Company LLC reiterated a "buy" rating and set a $11.00 target price on shares of CryoPort in a report on Thursday, May 8th. UBS Group raised their target price on CryoPort from $10.00 to $11.00 and gave the company a "buy" rating in a research note on Tuesday, April 1st. Roth Mkm restated a "buy" rating and set a $15.00 price target on shares of CryoPort in a research report on Tuesday, April 1st. Finally, Morgan Stanley decreased their price objective on CryoPort from $8.00 to $7.00 and set an "equal weight" rating for the company in a report on Monday, May 5th. Two research analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat, CryoPort presently has a consensus rating of "Moderate Buy" and an average price target of $11.00.

Hedge Funds Weigh In On CryoPort

Several large investors have recently modified their holdings of the stock. Cadian Capital Management LP grew its position in CryoPort by 14.1% during the 4th quarter. Cadian Capital Management LP now owns 4,927,027 shares of the company's stock valued at $38,332,000 after purchasing an additional 609,021 shares during the last quarter. Millennium Management LLC lifted its stake in shares of CryoPort by 11.0% in the fourth quarter. Millennium Management LLC now owns 4,139,869 shares of the company's stock worth $32,208,000 after buying an additional 409,353 shares in the last quarter. LPL Financial LLC lifted its stake in shares of CryoPort by 1,366.1% in the fourth quarter. LPL Financial LLC now owns 436,766 shares of the company's stock worth $3,398,000 after buying an additional 406,976 shares in the last quarter. Norges Bank purchased a new stake in shares of CryoPort during the fourth quarter valued at approximately $2,711,000. Finally, Silvercrest Asset Management Group LLC increased its position in shares of CryoPort by 77.0% during the fourth quarter. Silvercrest Asset Management Group LLC now owns 742,914 shares of the company's stock valued at $5,780,000 after acquiring an additional 323,216 shares in the last quarter. Hedge funds and other institutional investors own 92.90% of the company's stock.

CryoPort Company Profile

Cryoport, Inc provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services.